Structures by: Fábián L.
Total: 105
Theobromine trifluoroacetic acid
C7H8N4O2,C2HF3O2
Organic letters (2007) 9, 16 3133-3136
a=5.09253(14)Å b=8.33537(37)Å c=14.89683(42)Å
α=90.1645(18)° β=95.5873(17)° γ=99.7283(22)°
Theobromine malonic acid
C7H8N4O2,C3H4O4
Organic letters (2007) 9, 16 3133-3136
a=12.44248(60)Å b=12.90355(55)Å c=7.67255(26)Å
α=90° β=91.2464(23)° γ=90°
Cimetidinium fumarate acetonitrile solvate
C15H21.5N6.5O4S
CrystEngComm (2018) 20, 45 7242
a=13.7835(12)Å b=8.0156(7)Å c=18.7113(16)Å
α=90.00° β=107.4620(10)° γ=90.00°
Cimetidinium fumarate
C10H17N6S,C4H3O4
CrystEngComm (2018) 20, 45 7242
a=7.90643(32)Å b=8.3568(4)Å c=14.2156(5)Å
α=87.6100(33)° β=75.2582(30)° γ=76.179(5)°
Cimetidinium fumarate
C10H17N6S,C4H3O4
CrystEngComm (2018) 20, 45 7242
a=13.7700(10)Å b=8.0432(5)Å c=18.9493(10)Å
α=90.0° β=107.419(4)° γ=90.0°
Fenofibrate
C20H21ClO4
RSC Advances (2018) 8, 24 13513
a=8.1328(5)Å b=8.7088(6)Å c=13.6692(9)Å
α=85.976(6)° β=84.815(5)° γ=74.343(6)°
(1R*,2S*,4R*)-4-tert-butyl-2-hydroxy-1-cyclopentanecarboxylic acid
C10H18O3
Chemical Communications (2000) 22 2255
a=5.931(1)Å b=6.200(1)Å c=15.951(3)Å
α=84.30(4)° β=89.97(4)° γ=62.28(4)°
(1S*,2R*,4R*)-4-tert-butyl-2-hydroxy-1-cyclopentanecarboxylic acid
C10H18O3
Chemical Communications (2000) 22 2255
a=16.862(2)Å b=6.104(1)Å c=10.519(3)Å
α=90.00° β=107.03(4)° γ=90.00°
Cis(1R*,2S*)-2-hydroxy-1-cyclopentanecarboxamide
C6H11NO2
Chemical Communications (2000) 22 2255
a=11.693(2)Å b=7.225(1)Å c=7.902(2)Å
α=90.00° β=103.70(3)° γ=90.00°
Complex12
C4H8CdCl2N8
Chemical communications (Cambridge, England) (2010) 46, 48 9191-9193
a=3.76924(14)Å b=8.46664(23)Å c=17.1444(5)Å
α=90.0° β=95.185(4)° γ=90.0°
Complex11
C2H4CdCl2N4
Chemical communications (Cambridge, England) (2010) 46, 48 9191-9193
a=6.86493(22)Å b=8.96114(33)Å c=10.8252(5)Å
α=90.0° β=100.0015(24)° γ=90.0°
Zinc fumarate
C4H2O4Zn
CrystEngComm (2009) 11, 5 743
a=8.2406(4)Å b=5.21314(24)Å c=11.4415(6)Å
α=90.0° β=103.9094(24)° γ=90.0°
Zinc fumarate dihydrate
C4H6O6Zn
CrystEngComm (2009) 11, 5 743
a=3.39690(6)Å b=10.34413(24)Å c=8.80754(16)Å
α=90.0° β=95.5452(22)° γ=90.0°
Zinc(trans-1,2-bis(4-pyridyl)ethylene) fumarate
C10H7NO4Zn
CrystEngComm (2009) 11, 5 743
a=16.4332(9)Å b=10.7749(9)Å c=13.7840(12)Å
α=90.0° β=104.979(7)° γ=90.0°
2
C28H28MgO7
CrystEngComm (2011) 13, 9 3125
a=14.0543(3)Å b=6.1624(2)Å c=15.0156(5)Å
α=90.00° β=111.7970(10)° γ=90.00°
C28H26Mg1O10
C28H26Mg1O10
CrystEngComm (2011) 13, 9 3125
a=43.6732(37)Å b=5.88876(52)Å c=5.14629(39)Å
α=90° β=90° γ=90°
Isonicotinamide
C6H6N2O
CrystEngComm (2011) 13, 23 6923
a=11.0819(6)Å b=7.9976(4)Å c=9.9850(5)Å
α=90° β=94.0480(10)° γ=90°
C6H6N2O1
C6H6N2O1
CrystEngComm (2011) 13, 23 6923
a=5.1923(11)Å b=9.466(3)Å c=12.259(3)Å
α=90.00° β=91.217(7)° γ=90.00°
N-(4-methoxyphenyl)-N'-(piperidino)thiourea
C13H18N2OS
Green Chemistry (2012) 14, 9 2462
a=10.4930(2)Å b=14.6391(4)Å c=9.0779(2)Å
α=90.00° β=113.0210(10)° γ=90.00°
C24H23ClO2P2,H2O
C24H23ClO2P2,H2O
CrystEngComm (2007) 9, 7 561
a=12.277(2)Å b=16.356(2)Å c=23.341(4)Å
α=90.00° β=90.00° γ=90.00°
N-phenyl-N'-(thiomorpholino)thiourea
C11H14N2S2
Green Chemistry (2012) 14, 9 2462
a=11.5813(3)Å b=9.3856(3)Å c=10.8926(4)Å
α=90.00° β=101.21(3)° γ=90.00°
N,N'-bis(4-fluorophenyl)thiourea
C13H10F2N2S
Green Chemistry (2012) 14, 9 2462
a=8.3457(1)Å b=26.4224(2)Å c=5.3071(6)Å
α=90.00° β=90.00° γ=90.00°
N-(4-nitrophenyl)-N'-(morpholino)thiourea
C11H13N3O3S
Green Chemistry (2012) 14, 9 2462
a=10.2252(2)Å b=10.5172(3)Å c=11.1949(2)Å
α=90.00° β=90.788(2)° γ=90.00°
C15H16N2S1
C15H16N2S1
Green Chemistry (2012) 14, 9 2462
a=12.67213(25)Å b=9.79731(27)Å c=12.10093(31)Å
α=90° β=115.2231(14)° γ=90°
C14H14N2O1S1
C14H14N2O1S1
Green Chemistry (2012) 14, 9 2462
a=28.4936(24)Å b=5.55569(33)Å c=8.14303(38)Å
α=90° β=90.7479(43)° γ=90°
C14H13N3O2S1
C14H13N3O2S1
Green Chemistry (2012) 14, 9 2462
a=14.50439(92)Å b=13.62318(93)Å c=7.14076(26)Å
α=90° β=90° γ=90°
N-(4-nitrophenyl)-N'-(morpholino)thiourea
C11H13N3O3S1
Green Chemistry (2012) 14, 9 2462
a=21.2213(10)Å b=8.0908(4)Å c=28.6471(15)Å
α=90.00° β=90.00° γ=90.00°
7105349
Chemical communications (Cambridge, England) (2010) 46, 13 2224-2226
a=5.0907Å b=12.9686Å c=9.2368Å
α=94.0829° β=112.577° γ=104.714°
Theobromine acetic acid
C7H8N4O2,C2H4O2
Chemical communications (Cambridge, England) (2010) 46, 13 2224-2226
a=5.2185(4)Å b=8.2901(8)Å c=12.9358(11)Å
α=95.827(6)° β=96.854(6)° γ=100.333(8)°
Theophylline - DL-malic acid 1/1
C11H14N4O7
Chemical communications (Cambridge, England) (2008) 14 1644-1646
a=14.9572(8)Å b=6.07159(26)Å c=15.5163(6)Å
α=90.0° β=106.4298(17)° γ=90.0°
Theophylline - D-malic acid 1/1
C11H14N4O7
Chemical communications (Cambridge, England) (2008) 14 1644-1646
a=15.8592(8)Å b=6.07909(30)Å c=14.6549(9)Å
α=90.0° β=108.5890(19)° γ=90.0°
Artemisinin-resorcinol 2/1
2(C15H22O5),C6H6O2
CrystEngComm (2010) 12, 12 4038
a=9.5298(2)Å b=17.3699(4)Å c=10.4197(3)Å
α=90.00° β=94.0170(10)° γ=90.00°
Artemisinin-orcinol 1/1
C15H22O5,C7H8O2
CrystEngComm (2010) 12, 12 4038
a=9.0658(1)Å b=14.1061(3)Å c=16.5554(3)Å
α=90.00° β=90.00° γ=90.00°
3-Ethoxycarbonyl-2-phenyl-1,5-dihydro-4,1-benzothiazepine
C18H17NO2S
CrystEngComm (2010) 12, 6 1712
a=5.905(2)Å b=7.947(4)Å c=16.797(9)Å
α=90.00° β=97.611(15)° γ=90.00°
(R*)-3-Ethoxycarbonyl-2-phenyl-3,5-dihydro-4,1-benzothiazepine
C18H17NO2S
CrystEngComm (2010) 12, 6 1712
a=8.5761(11)Å b=9.7540(11)Å c=10.7880(14)Å
α=65.345(3)° β=73.471(3)° γ=72.509(3)°
3-Ethoxycarbonyl-2-(4-chlorophenyl)-1,5-dihydro-4,1- benzothiazepine
C19H19NO2S
CrystEngComm (2010) 12, 6 1712
a=7.75740(10)Å b=11.3316(2)Å c=17.9221(3)Å
α=90.00° β=90.00° γ=90.00°
(R*)-3-Ethoxycarbonyl-2-(4-chlorophenyl)-3,5-dihydro-4,1- benzothiazepine
C19H19NO2S
CrystEngComm (2010) 12, 6 1712
a=12.9550(4)Å b=7.1696(2)Å c=18.6157(8)Å
α=90.00° β=109.082(2)° γ=90.00°
3-Ethoxycarbonyl-2-(4-methylphenyl)-1,5-dihydro-4,1- benzothiazepine
C18H16ClNO2S
CrystEngComm (2010) 12, 6 1712
a=8.005(4)Å b=10.923(3)Å c=18.797(7)Å
α=90.00° β=90.00° γ=90.00°
(R*)-3-Ethoxycarbonyl-2-(4-methylphenyl)-3,5-dihydro-4,1- benzothiazepine
C18H16ClNO2S
CrystEngComm (2010) 12, 6 1712
a=12.699(2)Å b=7.2028(9)Å c=18.542(3)Å
α=90.00° β=108.578(6)° γ=90.00°
2-Ethoxycarbonyl-3-(4-chlorophenyl)-4,5-dihydro-7,8-dimethoxy- 1,4-benzothiazepine
C20H20ClNO4S
CrystEngComm (2010) 12, 6 1712
a=15.2508(4)Å b=9.1719(3)Å c=14.8923(4)Å
α=90.00° β=115.920(2)° γ=90.00°
Diphenyl [1-(3-phenylthioureido)benzyl]phosphonate
C26H23N2O3PS
Acta Crystallographica Section B (2004) 60, 2 211-218
a=9.9530(10)Å b=10.0460(10)Å c=12.7010(10)Å
α=96.660(10)° β=104.450(10)° γ=99.840(10)°
Diphenyl [(3-phenylthioureido)phenylpropyl]phosphonate
C28H27N2O3PS
Acta Crystallographica Section B (2004) 60, 2 211-218
a=9.9510(10)Å b=12.2010(10)Å c=11.8440(10)Å
α=100.400(10)° β=102.900(10)° γ=102.900(10)°
Diphenyl [2,2-dimethyl-1-(3-phenylthioureido)propyl]phosphonate
C24H27N2O3PS
Acta Crystallographica Section B (2004) 60, 2 211-218
a=10.688(3)Å b=9.888(2)Å c=22.961(2)Å
α=90.00° β=97.7900(10)° γ=90.00°
Trans-2-hydroxy-1-cyclopentane carboxylic acid
C6H10O3
Acta Crystallographica, Section B (2002) 58, 3 494-501
a=17.383(2)Å b=6.1880(10)Å c=12.3610(10)Å
α=90.00° β=101.160(10)° γ=90.00°
(1R*,2S*)-2-hydroxy-1-cyclohexanecarboxylic acid
C7H12O3
Acta Crystallographica, Section B (2002) 58, 3 494-501
a=21.436(8)Å b=5.9740(10)Å c=12.095(3)Å
α=90.00° β=97.70(3)° γ=90.00°
(1R*,2S*)-2-hydroxy-1-cycloheptane carboxylic acid
C8H14O3
Acta Crystallographica, Section B (2002) 58, 3 494-501
a=22.876(5)Å b=6.2240(10)Å c=11.793(2)Å
α=90.00° β=95.56(3)° γ=90.00°
(1R*,2R*)-trans-2-hydroxy-1-cyclooctanecarboxylic acid
C9H16O3
Acta Crystallographica Section B (2002) 58, 5 855-863
a=6.0350(10)Å b=8.3900(10)Å c=9.389(2)Å
α=84.290(10)° β=76.370(10)° γ=77.950(10)°
(1R*,2R*)-trans-2-hydroxy-1-cyclooctanecarboxamide ?
C9H17NO2
Acta Crystallographica Section B (2002) 58, 5 855-863
a=6.7600(10)Å b=7.3140(10)Å c=11.2170(10)Å
α=79.220(10)° β=74.120(10)° γ=69.450(10)°
(1R*,2S*)-cis-2-hydroxy-1-cyclooctanecarboxylic acid
C9H16O3
Acta Crystallographica Section B (2002) 58, 5 855-863
a=11.0820(10)Å b=7.6180(10)Å c=11.5790(10)Å
α=90.00° β=105.670(10)° γ=90.00°
Cis(1R*,2S*)-2-hydroxy-1-cyclopentanecarboxamide
C6H11NO2
Acta Crystallographica Section B (2001) 57, 4 539-550
a=11.693(2)Å b=7.2250(10)Å c=7.902(2)Å
α=90.00° β=103.70(3)° γ=90.00°
Trans(1S*,2S*)-2-hydroxy-1-cyclopentanecarboxamide
C6H11NO2
Acta Crystallographica Section B (2001) 57, 4 539-550
a=9.879(2)Å b=8.410(2)Å c=8.250(2)Å
α=90.00° β=90.00° γ=90.00°
(1S*,2R*,5R*)-5-tert-butyl-2-hydroxy-1-cyclopentanecarboxylic acid
C10H18O3
Acta Crystallographica Section B (2001) 57, 4 539-550
a=6.170(2)Å b=21.749(2)Å c=7.8920(10)Å
α=90.00° β=105.57(4)° γ=90.00°
(1R*,2S*,4R*)-4-tert-butyl-2-hydroxy-1-cyclopentanecarboxylic acid
C10H18O3
Acta Crystallographica Section B (2001) 57, 4 539-550
a=5.9310(10)Å b=6.2000(10)Å c=15.951(3)Å
α=84.30(4)° β=89.97(4)° γ=62.28(4)°
(1S*,2R*,4R*)-4-tert-butyl-2-hydroxy-1-cyclopentanecarboxylic acid
C10H18O3
Acta Crystallographica Section B (2001) 57, 4 539-550
a=16.862(2)Å b=6.1040(10)Å c=10.519(3)Å
α=90.00° β=107.03(4)° γ=90.00°
(1S*,2S*,4R*)-4-tert-butyl-2-hydroxy-1-cyclopentanecarboxamide
C10H19NO2
Acta Crystallographica Section B (2001) 57, 4 539-550
a=13.246(5)Å b=6.988(2)Å c=13.299(6)Å
α=90.00° β=113.78(8)° γ=90.00°
Trans-2-hydroxy-cycloheptanecarboxamide
C8H15N1O2
Acta Crystallographica Section B (2004) 60, 6 755-762
a=8.2480(10)Å b=19.679(3)Å c=10.5810(10)Å
α=90.00° β=90.00° γ=90.00°
Polypodine B hydrate
C27H44O8,H2O1
Acta Crystallographica Section B (2002) 58, 4 710-720
a=7.1630(10)Å b=10.3030(10)Å c=37.254(2)Å
α=90.00° β=90.00° γ=90.00°
Ecdysone
C27H44O6
Acta Crystallographica Section B (2002) 58, 4 710-720
a=7.7500(10)Å b=9.9350(10)Å c=35.6570(10)Å
α=90.00° β=90.00° γ=90.00°
20-hydroxyecdysone
C27H44O7
Acta Crystallographica Section B (2002) 58, 4 710-720
a=7.6630(10)Å b=10.5410(10)Å c=33.084(2)Å
α=90.00° β=90.00° γ=90.00°
20-hydroxyecdysone trihydrate
C27H50O10
Acta Crystallographica Section B (2002) 58, 4 710-720
a=11.293(2)Å b=14.202(2)Å c=18.721(3)Å
α=90.00° β=90.00° γ=90.00°
Cis-7-azabicyclo[4.2.0]octan-8-one
C7H11NO
Acta Crystallographica Section E (2004) 60, 2 o170-o172
a=11.3330(10)Å b=6.4740(10)Å c=10.1810(10)Å
α=90.00° β=112.000(10)° γ=90.00°
Amodiaquinium dihydrochloride dihydrate
C20H24Cl1N3O2,2Cl,2H2O
Acta Crystallographica Section E (2006) 62, 9 o4196-o4199
a=7.83868(10)Å b=26.9917(5)Å c=10.80804(18)Å
α=90° β=92.9632(13)° γ=90°
Diphenyl [3-methyl-1-(3-phenylthioureido)butyl]phosphonate
C24H27N2O3PS
Acta Crystallographica Section C (2003) 59, 1 o46-o50
a=10.1931(7)Å b=10.5503(5)Å c=11.9560(7)Å
α=90.932(4)° β=103.252(5)° γ=101.923(5)°
Diphenyl [2-methyl-1-(3-phenylthioureido)butyl]phosphonate
C24H27N2O3PS
Acta Crystallographica Section C (2003) 59, 1 o46-o50
a=9.9402(4)Å b=16.7505(6)Å c=14.1979(5)Å
α=90° β=91.973(3)° γ=90°
1:1 theophylline benzamide cocrystal Form I
C7H8N4O2,C7H7NO
Crystal Growth & Design (2015)
a=7.5275(2)Å b=13.3891(4)Å c=13.8564(4)Å
α=90.00° β=91.486(2)° γ=90.00°
1:1 theophylline acetamide cocrystal
C7H8N4O2,C2H5NO
Crystal Growth & Design (2015)
a=7.6545(13)Å b=8.3489(14)Å c=8.9540(16)Å
α=90.552(8)° β=91.339(11)° γ=110.177(12)°
1:1 theophylline N,N-dimethylformamide cocrystal
C7H8N4O2,C3H7NO
Crystal Growth & Design (2015)
a=4.4183(1)Å b=14.3872(6)Å c=19.3622(9)Å
α=90.00° β=93.41(3)° γ=90.00°
1:1 theophylline formamide cocrystal Form I
C7H8N4O2,CH3NO
Crystal Growth & Design (2015)
a=8.7314(3)Å b=6.6582(3)Å c=8.8996(4)Å
α=90.00° β=98.546(2)° γ=90.00°
1:1 theophylline formamide cocrystal Form II
C7H8N4O2,CH3NO
Crystal Growth & Design (2015)
a=6.6058(13)Å b=8.7163(17)Å c=8.8843(18)Å
α=81.34(3)° β=87.63(3)° γ=87.47(3)°
1:1 theophylline N-methylformamide cocrystal
C7H8N4O2,C2H5NO
Crystal Growth & Design (2015)
a=6.6316(3)Å b=8.7905(4)Å c=9.5955(4)Å
α=92.441(2)° β=92.929(2)° γ=90.609(2)°
1:1 theophylline pyrazinamide cocrystal Form II
C7H8N4O2,C5H5N3O
Crystal Growth & Design (2015)
a=7.4800(2)Å b=7.6959(2)Å c=12.7028(4)Å
α=86.113(2)° β=75.930(2)° γ=68.995(2)°
1:1 theophylline pyrazinamide cocrystal Form I
(C7H8N4O2),(C5H5N3O1)
Crystal Growth & Design (2015)
a=13.4545(15)Å b=13.2880(19)Å c=7.62149(40)Å
α=90° β=90° γ=90°
C20H21ClO4
C20H21ClO4
Crystal Growth & Design (2015) 15, 10 5011
a=9.4803(6)Å b=9.7605(6)Å c=10.9327(8)Å
α=110.840(6)° β=90.352(5)° γ=99.701(5)°
(E)-5-((E)-3-(1,4-bis(4-methoxyphenyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol- 3-yl)allylidene)-1,3-bis(4-methoxyphenyl)imidazolidine-2,4-dione
C36H31N5O7
Journal of Organic Chemistry (2006) 71, 7805-7812
a=10.517(1)Å b=12.589(1)Å c=13.854(1)Å
α=72.45(1)° β=70.51(1)° γ=70.07(1)°
C10H12O2,C6H6N2O
C10H12O2,C6H6N2O
Journal of Organic Chemistry (2011) 76, 1159-1162
a=5.9580(2)Å b=9.2476(3)Å c=14.1993(5)Å
α=91.391(2)° β=97.183(2)° γ=107.512(2)°
C32H36N4O6
C32H36N4O6
Journal of Organic Chemistry (2011) 76, 1159-1162
a=9.684(2)Å b=12.086(3)Å c=13.299(3)Å
α=81.860(6)° β=82.501(5)° γ=74.533(4)°
C11H14O2,C6H6N2O
C11H14O2,C6H6N2O
Journal of Organic Chemistry (2011) 76, 1159-1162
a=7.1279(4)Å b=8.8202(5)Å c=13.1405(8)Å
α=102.542(3)° β=92.659(3)° γ=95.430(3)°
C11H14O2,C6H6N2O
C11H14O2,C6H6N2O
Journal of Organic Chemistry (2011) 76, 1159-1162
a=9.6495(16)Å b=12.915(2)Å c=13.390(2)Å
α=102.007(3)° β=103.616(4)° γ=92.047(4)°
C11H14O2,C6H6N2O
C11H14O2,C6H6N2O
Journal of Organic Chemistry (2011) 76, 1159-1162
a=6.0360(2)Å b=9.4615(4)Å c=14.6013(5)Å
α=83.438(2)° β=84.291(2)° γ=71.750(2)°
C11H14O2,C6H6N2O
C11H14O2,C6H6N2O
Journal of Organic Chemistry (2011) 76, 1159-1162
a=5.5847(9)Å b=7.8959(12)Å c=17.784(3)Å
α=84.990(4)° β=85.314(4)° γ=83.194(4)°
C10H11FO2,C6H6N2O
C10H11FO2,C6H6N2O
Journal of Organic Chemistry (2011) 76, 1159-1162
a=13.397(5)Å b=9.956(3)Å c=12.273(4)Å
α=90° β=110.812(8)° γ=90°
C10H11FO2,C6H6N2O
C10H11FO2,C6H6N2O
Journal of Organic Chemistry (2011) 76, 1159-1162
a=8.8898(4)Å b=12.0610(5)Å c=15.2167(7)Å
α=72.416(2)° β=81.661(3)° γ=75.268(3)°
Kp118
C28H22ClN3O2S
Journal of Organic Chemistry (2003) 68, 5652-5659
a=7.517(1)Å b=15.096(2)Å c=20.836(2)Å
α=90.00° β=90.00° γ=90.00°
Kp137
C15H12N4
Journal of Organic Chemistry (2003) 68, 5652-5659
a=8.069(1)Å b=9.488(1)Å c=16.125(1)Å
α=90.00° β=103.17(1)° γ=90.00°
Kp158
C15H11ClN4
Journal of Organic Chemistry (2003) 68, 5652-5659
a=11.913(1)Å b=13.827(1)Å c=8.300(1)Å
α=90.00° β=90.51(1)° γ=90.00°
Kp83
C21H14Cl2N4S
Journal of Organic Chemistry (2003) 68, 5652-5659
a=10.904(1)Å b=18.298(1)Å c=10.284(1)Å
α=90.00° β=99.305(8)° γ=90.00°
Trans (1R*,2R*)-2-hydroxy-1-cycloheptanecarboxylic acid form A
C8H14O3
Journal of the American Chemical Society (2003) 125, 34-35
a=21.184(3)Å b=6.824(1)Å c=5.892(2)Å
α=90.00° β=90.00° γ=90.00°
Trans (1R*,2R*)-2-hydroxy-1-cycloheptanecarboxylic acid form B
C8H14O3
Journal of the American Chemical Society (2003) 125, 34-35
a=21.185(2)Å b=6.826(1)Å c=5.889(1)Å
α=90.00° β=90.00° γ=90.00°
Cis-2-aminocyclopentanecarboxylic acid
C6H11NO2
Crystal Growth & Design (2005) 5, 2 773
a=5.123(2)Å b=6.374(1)Å c=10.931(2)Å
α=97.90(1)° β=99.08(2)° γ=110.49(2)°
Cis-2-aminocyclohexanecarboxylic acid
C7H13NO2
Crystal Growth & Design (2005) 5, 2 773
a=5.160(1)Å b=6.383(1)Å c=12.281(1)Å
α=95.11(1)° β=100.51(1)° γ=108.97(1)°
Cis-2-aminocycloheptanecarboxylic acid
C8H15NO2
Crystal Growth & Design (2005) 5, 2 773
a=5.134(1)Å b=6.317(1)Å c=13.468(1)Å
α=101.50(1)° β=96.17(1)° γ=106.25(2)°
Cis-2-aminocyclooctanecarboxylic acid
C9H17NO2
Crystal Growth & Design (2005) 5, 2 773
a=5.397(1)Å b=6.338(1)Å c=13.743(1)Å
α=94.49(1)° β=98.66(1)° γ=105.94(2)°
Cis-2-aminocyclohex-4-enecarboxylic acid
C7H11NO2
Crystal Growth & Design (2005) 5, 2 773
a=11.757(1)Å b=5.159(1)Å c=12.075(1)Å
α=90.00° β=110.27(1)° γ=90.00°
3-exo-aminobicyclo[2.2.1]heptane-2-exo-carboxylic acid
C8H13NO2
Crystal Growth & Design (2005) 5, 2 773
a=23.387(1)Å b=6.654(1)Å c=10.007(1)Å
α=90.00° β=90.00° γ=90.00°
C16H18OS
C16H18OS
Crystal Growth & Design (2012) 12, 6 2969
a=5.5050(5)Å b=9.1593(9)Å c=13.5985(13)Å
α=83.769(2)° β=86.622(2)° γ=84.422(2)°
C13H12OS
C13H12OS
Crystal Growth & Design (2012) 12, 6 2969
a=5.6947(10)Å b=8.1334(13)Å c=25.063(5)Å
α=90° β=90° γ=90°
C12H10OS,C6F4I2
C12H10OS,C6F4I2
Crystal Growth & Design (2012) 12, 6 2969
a=10.2726(19)Å b=10.3038(19)Å c=11.177(2)Å
α=113.093(4)° β=108.007(5)° γ=100.815(5)°
C13H12OS,C6F4I2
C13H12OS,C6F4I2
Crystal Growth & Design (2012) 12, 6 2969
a=9.5808(6)Å b=22.0739(15)Å c=9.5433(6)Å
α=90° β=91.1500(10)° γ=90°
C13H12OS,C6F4I2
C13H12OS,C6F4I2
Crystal Growth & Design (2012) 12, 6 2969
a=14.198(4)Å b=5.8227(17)Å c=24.354(5)Å
α=90° β=90.205(5)° γ=90°
C12H8OS2,0.5(C6F4I2)
C12H8OS2,0.5(C6F4I2)
Crystal Growth & Design (2012) 12, 6 2969
a=4.1227(7)Å b=27.533(4)Å c=13.440(2)Å
α=90° β=97.344(3)° γ=90°